Multiplex Antibody Array Technology: Advantages and Applications
Proteomics remains essential to understanding disease mechanisms and identifying actionable biomarkers, but traditional methods often struggle to detect low-abundance proteins in complex biological samples.
|
In a recent article published in International Pharmaceutical Industry, Tebubio's Project Manager, Eric Mennesson, PhD, explores how multiplex antibody array technology is overcoming these limitations, enabling the simultaneous, high-sensitivity analysis of hundreds to thousands of proteins in a single assay. From biomarker discovery to decoding tumour microenvironment dynamics, this approach is accelerating both translational research and precision medicine strategies, offering new opportunities to better understand disease progression and treatment response. This publication highlights the growing role of advanced affinity-based technologies in complementing conventional proteomics and unlocking deeper biological insights. |
 |
||||
Accelerate your biomarker discovery with Tebubio’s Biomarker Mapping platform, combining high-throughput multiplex antibody arrays, advanced bioinformatics, and expert-led CRO support to deliver actionable insights from any biological sample.
Get in touch with the Tebubio team to discuss how we can help you achieve your research goals.
Originally published in International Pharmaceutical Industry (IPI).